Nogrip (Pheniramine Maleate, Ascorbic Acid, Paracetamol)

Pheniramine maleate is an H1‑receptor antagonist. By binding to histamine H1 receptors on mast cells and other tissues, it blocks the actions of histamine that cause itching, swelling, vasodilation and increased mucus production, thereby reducing the classic symptoms of allergic reactions.

The appropriate dose of Nogrip is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and any concomitant therapies. Patients should follow the prescriber’s instructions and the product label without altering the regimen on their own.

Safety of Nogrip in pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using the product.

To place an order, submit an enquiry on the Nogrip product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike single‑ingredient decongestants, Nogrip offers a multi‑component approach: an antihistamine for allergic symptoms, paracetamol for pain and fever, and vitamin C for antioxidant support. This combination can simplify therapy by reducing the need for multiple separate products, while still addressing the key symptoms of a common cold.

Nogrip should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its stability and potency throughout its shelf life.

Nogrip is intended for oral use. The tablet (or other oral dosage form) should be swallowed whole with a glass of water, unless otherwise directed by a healthcare professional. It is usually taken with or without food, as advised by the prescriber.

The most serious risks include severe allergic reactions such as anaphylaxis, and liver injury from excessive paracetamol exposure, especially when combined with alcohol or other hepatotoxic drugs. Patients should seek immediate medical attention if they experience rash, swelling, breathing difficulty, jaundice or unexplained fatigue.

Individuals with known hypersensitivity to pheniramine, paracetamol, ascorbic acid or any excipients should avoid Nogrip. It is also contraindicated in patients with severe liver disease, uncontrolled asthma triggered by antihistamines, or in children for whom the dosage has not been established without medical guidance.